Medicare Drug Coverage And Moral Hazard
Author:
Publisher
Health Affairs (Project Hope)
Subject
Health Policy
Reference13 articles.
1. M.V. Pauly and P.M. Danzon, “Insurance and New Technology: From Hospital to Drugstore,”Health Affairs(Sep/Oct 2001 ): 86 –100.
2. For a look at aggregated data, see F.R. Lichtenberg, “Are the Benefits of Newer Drugs Worth Their Cost? Evidence from the 1996 MEPS,”Health Affairs(Sep/Oct 2001 ): 241 –251. The great bulk of detailed studies of drug coverage explore the effects of introducing cost sharing for the atypical Medicaid population, a step not contemplated by any of the drug coverage proposals.
3. See S.B. Soumerai et al. “Payment Restrictions for Prescription Drugs under Medicaid: Effect on Therapy, Cost, and Equity,”New England Journal of Medicine(27 August 1987 ): 550 –556
4. ; and S.B. Soumerai et al. “Effects of Limiting Medicare Drug-Reimbursement Benefits on the Use of Psychotropic Agents and Acute Mental Health Services by Patients with Schizophrenia,”New England Journal of Medicine(8 September 1994 ): 650 –655.
5. R. Tamblyn , “The Impact of Pharmacotherapy Policy: A Case Study,”Canadian Journal of Clinical Pharmacology(Fall 2001 ): 39A –44A
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The effect of prescription drug insurance on the incidence of potentially inappropriate prescribing: Evidence from Medicare Part D;Health Economics;2023-10-21
2. Building ‘implicit partnerships’? Financial long-term care entitlements in Europe;Policy Sciences;2020-09-07
3. Distinguishing moral hazard from access for high-cost healthcare under insurance;PLOS ONE;2020-04-17
4. Features of anticholinergic prescriptions and predictors of high use in the elderly: Population‐based study;Pharmacoepidemiology and Drug Safety;2019-11-06
5. Factors Affecting Medicine-Induced Demand and Preventive Strategies: A Scoping Review;Shiraz E-Medical Journal;2019-09-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3